Cantargia AB (publ) (STO:CANTA)
Sweden · Delayed Price · Currency is SEK 1.532
-0.030 (-1.92%)
Sep 22, 2026, 5:29 PM CET
Cantargia AB Market Cap
Cantargia AB has a market cap or net worth of 388.33 million as of September 22, 2026. Its market cap has decreased by -44.71% in one year.
Market Cap
388.33M
Enterprise Value
166.38M
Revenue
317.31M
Ranking
n/a
PE Ratio
2.34
Stock Price
1.53
ChartMarket Cap Chart
Since March 17, 2015, Cantargia AB's market cap has increased from 120.55M to 388.33M, an increase of 222.12%. That is a compound annual growth rate of 10.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 388.33M | -62.68% |
| Dec 30, 2025 | 1.04B | 147.63% |
| Dec 30, 2024 | 420.15M | -38.81% |
| Dec 29, 2023 | 686.62M | 33.50% |
| Dec 30, 2022 | 514.32M | -72.19% |
| Dec 30, 2021 | 1.85B | -68.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oncopeptides AB | 834.85M |
| FluoGuide | 564.05M |
| Mendus AB | 448.29M |
| Xspray Pharma AB | 438.60M |
| Corline Biomedical AB | 371.09M |
| Intervacc AB | 344.22M |
| Sprint Bioscience AB | 301.77M |
| IRLAB Therapeutics AB | 258.76M |